<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318212</url>
  </required_header>
  <id_info>
    <org_study_id>DIS-2014-010</org_study_id>
    <nct_id>NCT02318212</nct_id>
  </id_info>
  <brief_title>Dilapan-S / Dilasoft E-Registry in Induced Abortion</brief_title>
  <acronym>DSREGISTRYIA</acronym>
  <official_title>International Observational E-Registry on the Use of Dilapan-S/Dilasoft Osmotic Dilators for Cervical Priming Prior to Induced Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicem International CR s.r.o.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medicem International CR s.r.o.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      International Observational E-Registry on the use of osmotic dilators DILAPAN-S® / DILASOFT®
      for cervical priming prior to induced abortion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      International, multicentre, non-interventional, observational e-registry, post market
      clinical follow up study to document current clinical use of Dilapan-S or Dilasoft for
      cervical priming before induced abortion with regard to the number of dilators used, duration
      of insertion of dilators in situ and unusual complications consequent of their use.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of inserted osmotic dilators</measure>
    <time_frame>max. up to 24 hrs; estimated average 6 hrs</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total time taken for cervical priming with Dilapan-S/Dilasoft</measure>
    <time_frame>max. up to 24 hrs; estimated average 6 hrs</time_frame>
    <description>Duration of leaving osmotic dilators in situ</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Type of synthetic osmotic dilator used</measure>
    <time_frame>max. up to 24 hrs; estimated average 6 hrs</time_frame>
    <description>Dilapan-S or Dilasoft</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during cervical priming</measure>
    <time_frame>up to 24 hrs; estimated average 6 hrs</time_frame>
    <description>pre-operative bleeding, fever, pain, nausea, vomiting, diarrhoea, premature passage of foetal or chorionic tissue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other observed undesirable effects uf use of synthetic osmotic dilators</measure>
    <time_frame>up to 24 hrs; estimated average 6 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of additional mechanical dilation</measure>
    <time_frame>up to 10 minutes after osmotic dilators extraction</time_frame>
    <description>In cases, when surgical abortion is performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical operative time</measure>
    <time_frame>estimated max. up to 10 min, estimated average 8 min.</time_frame>
    <description>Period from speculum insertion in to speculum extraction out</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Initiation-to-delivery time</measure>
    <time_frame>hrs</time_frame>
    <description>In case of medical abortion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Induction-to-delivery time</measure>
    <time_frame>up to 72 hrs; estimated average 48 hrs</time_frame>
    <description>In case of medical abortion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications related to induced abortion procedure</measure>
    <time_frame>up to 24 hrs; estimated average 12 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infectious complication and its relation to the use of Dilapan-S/Dilasoft</measure>
    <time_frame>up to 72 hrs; Complications, if any, will be followed-up until stable situation has been reached.</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">439</enrollment>
  <condition>Abortion, Induced</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilapan-S</intervention_name>
    <description>Synthetic osmotic dilators Dilapan-S or Dilasoft for cervical priming prior to induced abortion</description>
    <other_name>Dilasoft</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients indicated for cervical priming with Dilapan-S or Dilasoft prior to induced
        abortion and meet all inclusion and exclusion criteria in centres involved in data
        collection.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intrauterine pregnancy ≥ 6 and ≤ 24 weeks gestation

          -  Patients who are capable of giving consent and sign the form

          -  Abortion being made in compliance with the Abortion Act 1967 (For England, Wales and
             Scotland)

        Exclusion Criteria:

          -  Clinical signs of uterine, vaginal or vulvar infection

          -  Acute bleeding
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Lohr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>British Pregnancy Advisory Service, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jiri Hanacek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Care for Mother and Child, Prague, CZ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Natalia Kan, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Obstetrics, Gynecology and Perinatology, Moscow</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Roizin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allentown Women´s Center, Bethlehem, PA, US</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary Jane Bovo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Choices Women´s Medical Center, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LeRoy Carhart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germantown Reproductive Health Service</affiliation>
  </overall_official>
  <reference>
    <citation>Allen RH, Goldberg AB; Board of Society of Family Planning. Cervical dilation before first-trimester surgical abortion (&lt;14 weeks' gestation). SFP Guideline 20071. Contraception. 2007 Aug;76(2):139-56. Epub 2007 Jul 10.</citation>
    <PMID>17656184</PMID>
  </reference>
  <reference>
    <citation>Fox MC, Krajewski CM. Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4. Contraception. 2014 Feb;89(2):75-84. doi: 10.1016/j.contraception.2013.11.001. Epub 2013 Nov 11.</citation>
    <PMID>24331860</PMID>
  </reference>
  <reference>
    <citation>Newmann S, Dalve-Endres A, Drey EA; Society of Family Planning. Clinical guidelines. Cervical preparation for surgical abortion from 20 to 24 weeks' gestation. Contraception. 2008 Apr;77(4):308-14. doi: 10.1016/j.contraception.2008.01.004. Epub 2008 Mar 4.</citation>
    <PMID>18342657</PMID>
  </reference>
  <reference>
    <citation>Schulz KF, Grimes DA, Cates W Jr. Measures to prevent cervical injury during suction curettage abortion. Lancet. 1983 May 28;1(8335):1182-5.</citation>
    <PMID>6133988</PMID>
  </reference>
  <reference>
    <citation>Lichtenberg ES. Complications of osmotic dilators. Obstet Gynecol Surv. 2004 Jul;59(7):528-36. Review.</citation>
    <PMID>15199271</PMID>
  </reference>
  <reference>
    <citation>Samuel MI, Parsons JH. Hygroscopic dilator (Dilapan-S) and misoprostol combination for the early first-trimester termination of pregnancy: a pilot study. J Fam Plann Reprod Health Care. 2009 Jan;35(1):45-7. doi: 10.1783/147118909787072234.</citation>
    <PMID>19126319</PMID>
  </reference>
  <reference>
    <citation>Chambers DG, Willcourt RJ, Laver AR, Baird JK, Herbert WY. Comparison of Dilapan-S and laminaria for cervical priming before surgical pregnancy termination at 17-22 weeks' gestation. Int J Womens Health. 2011;3:347-52. doi: 10.2147/IJWH.S25551. Epub 2011 Oct 20.</citation>
    <PMID>22114527</PMID>
  </reference>
  <reference>
    <citation>Chen FC, Bergann A, Krosse J, Merholz A, David M. Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan-S for cervical ripening before first trimester curettage. Eur J Obstet Gynecol Reprod Biol. 2008 Jun;138(2):176-9. Epub 2007 Nov 5.</citation>
    <PMID>17980952</PMID>
  </reference>
  <reference>
    <citation>Bartz D, Maurer R, Allen RH, Fortin J, Kuang B, Goldberg AB. Buccal misoprostol compared with synthetic osmotic cervical dilator before surgical abortion: a randomized controlled trial. Obstet Gynecol. 2013 Jul;122(1):57-63. doi: 10.1097/AOG.0b013e3182983889.</citation>
    <PMID>23743471</PMID>
  </reference>
  <reference>
    <citation>Lyus R, Lohr PA, Taylor J, Morroni C. Outcomes with same-day cervical preparation with Dilapan-S osmotic dilators and vaginal misoprostol before dilatation and evacuation at 18 to 21+6 weeks' gestation. Contraception. 2013 Jan;87(1):71-5. doi: 10.1016/j.contraception.2012.07.006. Epub 2012 Aug 13.</citation>
    <PMID>22898362</PMID>
  </reference>
  <reference>
    <citation>Poon LC, Parsons J. Audit of the effectiveness of cervical preparation with Dilapan prior to late second-trimester (20-24 weeks) surgical termination of pregnancy. BJOG. 2007 Apr;114(4):485-8. Epub 2007 Feb 19.</citation>
    <PMID>17309543</PMID>
  </reference>
  <reference>
    <citation>Newmann SJ, Sokoloff A, Tharyil M, Illangasekare T, Steinauer JE, Drey EA. Same-day synthetic osmotic dilators compared with overnight laminaria before abortion at 14-18 weeks of gestation: a randomized controlled trial. Obstet Gynecol. 2014 Feb;123(2 Pt 1):271-8. doi: 10.1097/AOG.0000000000000080.</citation>
    <PMID>24402587</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cervical dilatation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

